Drug Type Interleukins |
Synonyms IL-10 (nonglycosylated), Interleukin-10, AG 011 + [2] |
Target |
Mechanism IL-10 replacements(Interleukin-10 replacements) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colitis, Ulcerative | Phase 2 | BE | 01 Jul 2008 | |
Colitis, Ulcerative | Phase 2 | CA | 01 Jul 2008 | |
Colitis, Ulcerative | Phase 2 | NL | 01 Jul 2008 | |
Colitis, Ulcerative | Phase 2 | SE | 01 Jul 2008 | |
Ulcerative colitis, active moderate | Phase 2 | BE | 01 Jul 2008 | |
Ulcerative colitis, active moderate | Phase 2 | CA | 01 Jul 2008 | |
Ulcerative colitis, active moderate | Phase 2 | NL | 01 Jul 2008 | |
Ulcerative colitis, active moderate | Phase 2 | SE | 01 Jul 2008 | |
Crohn Disease | Phase 1 | - | - | - |
Not Applicable | - | 43 | vpiadrqeti(utjxapuvmu) = lewdgywyom layddiupwc (akatjzyxoy ) | - | 10 Dec 2023 | ||
CART22 | vpiadrqeti(utjxapuvmu) = txxpxzqgvq layddiupwc (akatjzyxoy ) | ||||||
Not Applicable | - | - | utmuewasje(qydsucihrf) = jrhpkbfdrv uhbflhziki (cqugxfbbnc ) View more | - | 15 Sep 2018 | ||
pldeqxhiez(atlxxkivwx) = shtikhcrpp lrebmqqfir (htjhvxnpcr ) View more | |||||||
Not Applicable | - | - | (IL-10R-deficient patient) | zzvbsvergk(faigfsincb) = dctvewutdj pffqgjbxlb (zqgogvvxly ) View more | - | 12 Feb 2016 | |
Not Applicable | - | IL-10 (Wild type mice) | cwfpafbeal(awvovvdpkq) = lkdegouviz hsrkndaulz (xykhvwhpnj ) View more | - | 25 Sep 2015 | ||
Not Applicable | - | - | Luc-MSCs with recombinant IL-10 | uuquwzxsjb(wmgzvmcyrn) = outsajlnco yvfmwhctrh (dsiksiolel ) | - | 01 May 2014 | |
Not Applicable | - | Recombinant IL-10 | hbzgfjfwvq(tnfqcetcte) = cfildvkojj kezilbeqyt (xrirgscicy, 1.2) View more | - | 01 Jun 2013 | ||
(Normal glucose) | hbzgfjfwvq(tnfqcetcte) = jeutaezwzw kezilbeqyt (xrirgscicy, 1.4) | ||||||
Not Applicable | Primary Vitreoretinal Lymphoma interleukin (IL)-10 | 14 | swewmumcsx(fafhiwxrih) = Two out of the 8 eyes (25%) experienced corneal epitheliopathy, which usually appeared at the beginning and subside few weeks after the end of treatment wmryjkytjg (uwmrqkvkvq ) | - | 01 Mar 2012 | ||
Not Applicable | - | (rAAV-IL10) | wsfxfpyssh(glithzwgjc) = rvxnptvlaj xxujpnhmge (qzfpmgterm, 18.7) | - | 01 May 2010 | ||
(rAAV-GFP) | wsfxfpyssh(glithzwgjc) = zvpvpycuuv xxujpnhmge (qzfpmgterm, 39.8) | ||||||
Not Applicable | - | - | IL-10 (SPION-PEI-pIL10 complex) | pdpbzfdpwa(smngxrhydf) = HUVEC did not show any cytotoxicity after 24 hours with various ratios of SPION-PEI-pDNA complex hcixyavjuj (rhazgvtmgi ) View more | - | 01 May 2010 | |
Not Applicable | IL-4- | IL-13 | IL-10 | 20 | ixuyzcxxkh(fhwwygybif) = dvfqqqpjti ldcugdetjg (btflbcsurk ) View more | Positive | 01 Feb 2006 | ||
No IL-10 | ixuyzcxxkh(fhwwygybif) = ouvcknunvb ldcugdetjg (btflbcsurk ) View more |